Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, and diagnosis of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.
Stock data | 2023 | Change |
---|---|---|
Price | $25.37 | N/A |
Market Cap | $1.30B | N/A |
Shares Outstanding | 51.20M | 0.08% |
Employees | 4.30K | N/A |
Shareholder Equity | 9.91B | 11.55% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.91 | N/A |
P/S Ratio | 9.50 | N/A |
P/B Ratio | 0.13 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0017 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $136.78M | N/A |
Earnings | $17.08M | N/A |
EPS | 27.81 | N/A |
Earnings Yield | 1.10 | N/A |
Gross Margin | 0.7703 | N/A |
Operating Margin | 0.1819 | N/A |
Net income margin | 0.1249 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $178.88M | N/A |
Total Debt | $31.73M | N/A |
Cash on Hand | $11.21M | N/A |
Debt to Equity | 0.0061 | -28.67% |
Cash to Debt | 0.3531 | -25.98% |
Current Ratio | $1.14 | -12.36% |